Radiolytic Nanoparticle Delivery of Radiation Sensitizers for BRCA-Proficient Triple Negative Breast Cancer

被引:0
|
作者
DuRoss, A. N. [1 ]
Rosch, J. [1 ]
Brown, A. [1 ]
Sahay, G. [1 ]
Jaboin, J. J. [2 ]
Thomas, C. R., Jr. [2 ,3 ]
Sun, C. [1 ,2 ]
机构
[1] Oregon State Univ, Corvallis, OR 97331 USA
[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
关键词
D O I
10.1016/j.ijrobp.2017.06.2012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3396
引用
收藏
页码:E586 / E587
页数:2
相关论文
共 50 条
  • [1] PI3K Inhibitor Increased Radiosensitizing Effect of PARP Inhibitor in BRCA-Proficient Triple Negative Breast Cancer Cells
    Kim, I. A.
    Jang, N. Y.
    Kim, D. H.
    Cho, B. J.
    Choi, E. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E533 - E534
  • [2] Discovery of novel PARP/PI3K dual inhibitors with high efficiency against BRCA-proficient triple negative breast cancer
    Wang, Junwei
    He, Guangchao
    Li, Hui
    Ge, Yiran
    Wang, Shuping
    Xu, Yungen
    Zhu, Qihua
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 213
  • [3] PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition
    Ibrahim, Yasir H.
    Garcia-Garcia, Celina
    Serra, Violeta
    He, Lei
    Torres-Lockhart, Kristine
    Prat, Aleix
    Anton, Pilar
    Cozar, Patricia
    Guzman, Marta
    Grueso, Judit
    Rodriguez, Olga
    Teresa Calvo, Maria
    Aura, Claudia
    Diez, Orland
    Rubio, Isabel T.
    Perez, Jose
    Rodon, Jordi
    Cortes, Javier
    Ellisen, Leif W.
    Scaltriti, Maurizio
    Baselga, Jose
    CANCER DISCOVERY, 2012, 2 (11) : 1036 - 1047
  • [4] Olaparib enhances sensitization of BRCA-proficient breast cancer cells to x-rays and protons
    Park, Sohee
    Choi, Changhoon
    Kim, Haeyoung
    Shin, Yong Jae
    Oh, Yunjeong
    Park, Won
    Cho, Won Kyung
    Kim, Nalee
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (03) : 449 - 461
  • [5] BKM120 sensitizes BRCA-proficient triple negative breast cancer cells to olaparib through regulating FOXM1 and Exo1 expression
    Yu Li
    Yuantao Wang
    Wanpeng Zhang
    Xinchen Wang
    Lu Chen
    Shuping Wang
    Scientific Reports, 11
  • [6] BKM120 sensitizes BRCA-proficient triple negative breast cancer cells to olaparib through regulating FOXM1 and Exo1 expression
    Li, Yu
    Wang, Yuantao
    Zhang, Wanpeng
    Wang, Xinchen
    Chen, Lu
    Wang, Shuping
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [7] Olaparib enhances sensitization of BRCA-proficient breast cancer cells to x-rays and protons
    Sohee Park
    Changhoon Choi
    Haeyoung Kim
    Yong Jae Shin
    Yunjeong Oh
    Won Park
    Won Kyung Cho
    Nalee Kim
    Breast Cancer Research and Treatment, 2024, 203 : 449 - 461
  • [8] mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize with PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer
    Mo, Wei
    Liu, Qingxin
    Lin, Curtis Chun-Jen
    Dai, Hui
    Peng, Yang
    Liang, Yulong
    Peng, Guang
    Meric-Bernstam, Funda
    Mills, Gordon B.
    Li, Kaiyi
    Lin, Shiaw-Yih
    CLINICAL CANCER RESEARCH, 2016, 22 (07) : 1699 - 1712
  • [9] Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibition
    Villamar Cruz, Olga
    Prudnikova, Tatiana Y.
    Araiza-Olivera, Daniela
    Perez-Plasencia, Carlos
    Johnson, Neil
    Bernhardy, Andrea J.
    Slifker, Michael
    Renner, Catherine
    Chernoff, Jonathan
    Arias-Romero, Luis E.
    ONCOTARGET, 2016, 7 (47) : 76590 - 76603
  • [10] The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer
    Hou, Ming-Feng
    Luo, Chi-Wen
    Chang, Tsung-Ming
    Hung, Wen-Chun
    Chen, Tzu-Yi
    Tsai, Ya-Li
    Chai, Chee-Yin
    Pan, Mei-Ren
    EXPERIMENTAL CELL RESEARCH, 2017, 359 (02) : 458 - 465